These results provide new insights into the occurrence and progression of ESCC and indicate that the S1P/S1PR1/SAA1/β-catenin axis may serve as a potential therapeutic target in ESCC. The gene discussed is S1PR1; the disease is esophageal squamous cell carcinoma.